FUJI PHARMA CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,507 JPY | -1.44% |
|
-3.65% | -13.40% |
| 2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
| 2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
Chart calendar Fuji Pharma Co., Ltd.
3029de3bdee4.S5kLlXWOlf_no5iuUbwdREbv_9sDRqxVgtuRwJ4LKH0.Dqx-zCb52oyDwN6XBth0JTyLqPZnE9Q-8qzXstJlbRg6zEPUJcTSiIKQwQ~47c908c972928f38613e3c2bb67f3b6b
Upcoming events on Fuji Pharma Co., Ltd.
Past events on Fuji Pharma Co., Ltd.
| 2024-05-08 | Q2 2024 Earnings Release |
| 2024-03-27 | Ex-dividend day for interim dividend |
| 2024-02-07 | Q1 2024 Earnings Release |
| 2023-11-08 | Q4 2023 Earnings Call |
| 2023-11-08 | Q4 2023 Earnings Release |
| 2023-09-27 | Final dividend |
| 2023-08-07 | Q3 2023 Earnings Call |
| 2023-08-07 | Q3 2023 Earnings Release |
| 2023-05-10 | Q2 2023 Earnings Call |
| 2023-05-10 | Q2 2023 Earnings Release |
| 2023-03-29 | Ex-dividend day for interim dividend |
| 2023-02-08 | Q1 2023 Earnings Release |
| 2022-12-20 01:00 | Annual General Meeting |
| 2022-11-09 | FY 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for final dividend |
| 2022-08-04 | Q3 2022 Earnings Release |
| 2022-05-05 | Interim 2022 Earnings Call |
| 2022-05-05 | Interim 2022 Earnings Release |
| 2022-03-29 | Ex-dividend day for interim dividend |
| 2022-02-03 | Q1 2022 Earnings Call |
Past dividends on Fuji Pharma Co., Ltd.
| 2024-03-27 | Interim Payment 20 JPY |
| 2023-09-27 | Final Payment 20 JPY |
| 2023-03-29 | Interim Payment 17 JPY |
| 2022-09-28 | Final Payment 20 JPY |
| 2022-03-29 | Interim Payment 15 JPY |
| 2021-09-28 | Final Payment 15 JPY |
| 2021-03-29 | Interim Payment 14 JPY |
| 2020-09-28 | Final Payment 15 JPY |
| 2020-03-29 | Interim Payment 14 JPY |
| 2019-09-26 | Final Payment 15 JPY |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 36 279 37 250 -2.61% | 33 793 33 600 0.57% | 33 990 34 600 -1.76% | 35 426 35 750 -0.91% | 40 889 42 175 -3.05% | 45 264 |
|
EBITDA Million JPY | Released Forecast Spread | 6 302 6 650 -5.23% | 5 196 4 750 9.39% | 5 455 4 850 12.47% | 6 522 5 550 17.51% | 6 881 6 700 2.71% | 8 016 |
|
EBIT Million JPY | Released Forecast Spread | 4 173 4 650 -10.26% | 3 139 2 950 6.41% | 3 349 3 075 8.91% | 3 777 3 595 5.06% | 3 858 3 675 4.98% | 3 878 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 3 961 4 650 -14.82% | 2 918 2 635 10.74% | 3 371 3 105 8.57% | 3 723 3 750 -0.72% | 4 399 3 955 11.23% | 7 028 |
|
Net income Million JPY | Released Forecast Spread | 2 962 3 450 -14.14% | 2 085 1 750 19.14% | 2 432 2 175 11.82% | 2 696 2 635 2.31% | 3 435 2 875 19.48% | 5 829 |
|
EPS JPY | Released Forecast Spread | 97,0 113 -14.12% | 66,9 56,2 19.11% | 90,5 89,6 1.11% | 111 108 2.36% | 141 118 19.5% | 240 |
| Announcement Date | 08/11/19 | 05/11/20 | 05/11/21 | 10/11/22 | 09/11/23 | - |
Quarterly results
| Fiscal Period | September | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 16 905 16 700 1.23% | 17 277 17 400 -0.71% | 9 446 9 300 1.57% | 8 280 8 504 -2.63% | 17 726 17 950 -1.25% | 8 744 9 074 -3.64% | 8 956 9 030 -0.82% | 9 996 10 300 -2.95% | 19 225 20 000 -3.88% | 10 257 11 475 -10.61% | 11 407 11 018 3.53% | 10 746 11 700 -8.15% | 10 642 11 254 -5.44% | 21 388 22 354 -4.32% | ||
|
EBIT Million JPY | Released Forecast Spread | 1 735 1 200 44.58% | 2 686 1 550 73.29% | 1 562 1 100 42% | 1 150 738 55.83% | 2 712 2 300 17.91% | 900 688 30.81% | 165 -112 247.32% | 1 190 1 100 8.18% | 1 824 2 100 -13.14% | 579 1 176 -50.77% | 1 455 897 62.21% | -140 1 600 -108.75% | 1 583 2 040 -22.4% | 1 443 1 443 0.03% | ||
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 423 | 2 871 | 1 581 1 120 41.16% | 1 284 749 71.43% | 2 865 2 330 22.96% | 961 574 67.42% | -103 -78,0 -32.05% | 1 579 1 150 37.3% | 2 456 2 150 14.23% | 285 1 044 -72.7% | 1 658 1 059 56.56% | 3 856 1 900 102.95% | 6 027 | |||
|
Net income Million JPY | Released Forecast Spread | 310 804 -61.44% | 2 021 1 100 83.73% | 1 118 818 36.67% | 716 583 22.81% | 1 834 1 701 7.82% | 808 574 40.77% | 54,0 58,0 -6.9% | 1 114 828 34.54% | 1 772 1 548 14.47% | 210 748 -71.93% | 1 453 768 89.19% | 2 739 1 368 100.22% | 1 518 1 211 25.35% | 4 257 3 719 14.47% | 1 050 | 1 000 |
|
EPS JPY | Released Forecast Spread | 9,98 | 68,6 | 46,1 | 75,5 | 33,3 | 45,9 | 73,0 | 8,63 | 113 | 175 144 22.06% | ||||||
| Announcement Date | 08/05/20 | 07/05/21 | 04/02/22 | 06/05/22 | 06/05/22 | 05/08/22 | 10/11/22 | 09/02/23 | 11/05/23 | 08/08/23 | 09/11/23 | 08/02/24 | 09/05/24 | 09/05/24 | - | - |
More events
Past sector events for Fuji Pharma Co., Ltd.
| 2024-05-14 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-14 17:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 | BAYER AG: Q1 2024 Earnings Release |
| 2024-05-13 | SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | PRESTIGE CONSUMER HEALTHCARE INC.: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4554 Stock
- Calendar Fuji Pharma Co., Ltd.